New tests of a recently approved RSV vaccine show potent antibody response to current and past variants

New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range of variants producing potent antibody responses against current and past strains, and may even bode well against future viral offshoots.

Leave A Comment

Your email address will not be published. Required fields are marked *